CXCL13 and Hodgkins lymphoma: We evaluated the differential expression of CXCL13 in the 88 iMCD patient samples in the Primary cohort compared to 20 rheumatoid arthritis (RA) patients, 20 Hodgkin lymphoma (HL) patients, and 20 HHV8-associated MCD (HHV8-MCD) patients.